-Increased pathogenesis of gliomas by overactivating IDO-1 through the production of inflammatory cytokines, amyloid peptide, and lipopolysaccharides. -IDO-1-suppressed expansions of T-cells and other immune cells via tryptophan depletion route (see above). Here, IDO1 is linked to central nervous system cancer.